Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events
| Image |  |
|---|---|
| Description | scientific article published on 28 October 2013 |
| Author/s |
author: Andrea De Luca Manuela Colafigli Simona Di Giambenedetto Annalisa Mondi Nicoletta Ciccarelli Letizia Sidella Alessandro D'Avino Gabriella d'Ettorre Vincenzo Vullo Serena Fortuna Rita Murri Roberto Cauda Massimiliano Fabbiani |
| Publication date | October 28, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |